iRhythm Technologies, Inc. (NASDAQ:IRTC) Holdings Lowered by Polar Asset Management Partners Inc.

Polar Asset Management Partners Inc. reduced its stake in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 88.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,000 shares of the company's stock after selling 82,300 shares during the period. Polar Asset Management Partners Inc.'s holdings in iRhythm Technologies were worth $992,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. R Squared Ltd bought a new position in iRhythm Technologies in the 4th quarter worth $45,000. Van ECK Associates Corp increased its holdings in shares of iRhythm Technologies by 41.3% in the 4th quarter. Van ECK Associates Corp now owns 554 shares of the company's stock worth $50,000 after buying an additional 162 shares during the last quarter. Raiffeisen Bank International AG bought a new stake in shares of iRhythm Technologies in the 4th quarter worth about $60,000. Nisa Investment Advisors LLC increased its holdings in shares of iRhythm Technologies by 166.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company's stock worth $94,000 after buying an additional 648 shares during the last quarter. Finally, KBC Group NV grew its holdings in iRhythm Technologies by 45.1% during the 4th quarter. KBC Group NV now owns 1,319 shares of the company's stock valued at $119,000 after purchasing an additional 410 shares during the last quarter.

Wall Street Analyst Weigh In

A number of brokerages have commented on IRTC. Wall Street Zen downgraded shares of iRhythm Technologies from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Robert W. Baird upped their price target on shares of iRhythm Technologies from $133.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Needham & Company LLC increased their price objective on shares of iRhythm Technologies from $138.00 to $151.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Citigroup raised their price target on shares of iRhythm Technologies from $130.00 to $167.00 and gave the company a "buy" rating in a research report on Thursday, May 22nd. Finally, Truist Financial increased their price objective on shares of iRhythm Technologies from $111.00 to $145.00 and gave the company a "buy" rating in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $133.73.

iRhythm Technologies Price Performance

Shares of IRTC stock traded down $0.87 during trading hours on Friday, hitting $141.37. The company's stock had a trading volume of 787,545 shares, compared to its average volume of 481,396. The business has a fifty day moving average of $118.50 and a 200-day moving average of $105.44. The stock has a market cap of $4.51 billion, a price-to-earnings ratio of -38.84 and a beta of 1.34. iRhythm Technologies, Inc. has a twelve month low of $55.92 and a twelve month high of $146.58. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported ($0.95) earnings per share for the quarter, missing analysts' consensus estimates of ($0.89) by ($0.06). iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. The company had revenue of $158.68 million during the quarter, compared to analyst estimates of $153.39 million. During the same quarter last year, the business earned ($1.23) EPS. The firm's revenue for the quarter was up 20.3% compared to the same quarter last year. As a group, equities research analysts anticipate that iRhythm Technologies, Inc. will post -1.98 EPS for the current year.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.